Status:
UNKNOWN
Exercise and Quality of Life During Androgen Deprivation Therapy
Lead Sponsor:
Tampere University Hospital
Collaborating Sponsors:
Varalan urheiluopisto
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This study evaluates effects of supervised exercise in reducing adverse effects of hormonal treatment, increasing quality of life and in inducing a long-term change into more active lifestyle in prost...
Detailed Description
Androgen deprivation therapy (ADT) is commonly used in management of advanced or recurrent prostate cancer. It also frequently used adjuvant to curative-intent radiation therapy for localized prostate...
Eligibility Criteria
Inclusion
- Undergoing castration treatment for prostate cancer
- Informed consent for the study
Exclusion
- Unable to participate in exercise (ECOG 2 or greater)
- High bone fracture risk (as judged by the primary physician)
- Unable to understand spoken and written instructions in Finnish
Key Trial Info
Start Date :
August 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04050397
Start Date
August 15 2019
End Date
August 15 2021
Last Update
September 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University Hospital
Tampere, Finland, 33520